Navigation Links
Study Finds Older Corneas Suitable for Transplantation
Date:4/1/2008

Tissue from people up to 75 had similar survival rates to that from younger donors

TUESDAY, April 1 (HealthDay News) -- People up to the age of 75 should be allowed to donate corneas for transplant, says a U.S. National Eye Institute-funded study.

The researchers found that tissue from donors aged 66 to 75 had the same five-year success rate (86 percent) as corneas from donors aged 12 to 65.

The research, coordinated by the Jaeb Center for Health Research in Tampa, Fla., included 1,101 patients, aged 40 to 80, enrolled by 105 surgeons at 80 sites. The patients were followed for five years after corneal transplant. A transplant was considered a failure if a repeat corneal transplant was needed or if the transplanted cornea was cloudy for at least three months.

The findings were published in the April issue of Ophthalmology.

This is "the largest study of its type on corneal transplantation ever done. Its size and five-year patient follow-up, along with a simple trial design, have provided us with clear and important insights into contemporary transplantation," study co-chairman Dr. Mark J. Mannis, professor and chairman of the department of ophthalmology at the University of California, Davis, said in a prepared statement.

In the United States, more than 33,000 corneal transplants are done each year. For the past 10 years, there's been an adequate supply of donor corneas, the study authors noted. However, supply could become a problem due to new U.S. Food and Drug Administration regulations that require additional screening and testing of potential donors for contagious diseases, registration of eye banks, more detailed records and labels, and stricter quarantine procedures.

In addition, some surgeons are reluctant to use corneas from older people, so many eye banks only accept corneas from donors aged 65 or younger.

The study authors said the use of corneas from older donors could expand the donor pool by as much as 20 percent to 35 percent.

"Surgeons and patients now have scientific evidence that older donor corneas are suitable for transplantation," study co-chairman Dr. Edward J. Holland, a professor of ophthalmology at the University of Cincinnati and director of the Cornea Service at the Cincinnati Eye Institute, said in a prepared statement. "Further, when corneas are readily available, transplant procedures can be scheduled more efficiently, allowing both surgeons and patients to plan for them."

The findings have come at a good time, according to Dr. Paul A. Sieving, director of the National Eye Institute.

"The pressure on eye banks to provide corneas is increasing. The results of this study will expand the available donor pool and should persuade surgeons to use corneas from older donors. These changes will greatly benefit the growing number of individuals who need corneal transplants," Sieving said in a prepared statement.

More information

The Eye Bank Association of America has more about corneal transplant.



-- Robert Preidt



SOURCE: U.S. National Eye Institutes, news release, April 1, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study Finds Older Corneas Suitable for Transplantation
(Date:1/24/2017)... ... 2017 , ... Element Blue ™, a leading IT ... partnership with Lucidworks , the company transforming the way people access information, ... building powerful enterprise search applications. , Element Blue is a global team of ...
(Date:1/24/2017)... MD (PRWEB) , ... January 24, 2017 , ... ... by MSC Cruises as part of the line’s 4th Annual MSC True Partnerships’ ... top performing North American travel partners for the year based on overall business growth ...
(Date:1/24/2017)... PLYMOUTH MEETING, PA (PRWEB) , ... January 24, ... ... clinical healthcare advocacy company, announced today that its annual Solutions Series of webinars ... will feature industry thought leaders discussing a number of current health and benefits ...
(Date:1/24/2017)... Santa Margarita, CA (PRWEB) , ... January 24, 2017 , ... ... advancement platform for 21st century leadership, has named Hector M. Chavez, Manager, Employee & ... and diabetes treatment center - as its Hispanic Leader of the Month. City of ...
(Date:1/24/2017)... ... January 24, 2017 , ... ... to Thrive , Well-meaning studies such as the Fordham Institute’s High Stakes ... serve top students, such as including gifted or high-achieving students as a subgroup ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... -- Aptuit, LLC, hat heute den Beginn ... General Hospital (MGH) unter Leitung von Dr. Laurence ... und Validierung neuartiger Targets in gramnegativen Bakterien.  Aptuit erhofft ... Antibiotika bei der Behandlung schwerer Infektionen entgegenwirken können. ... ...
(Date:1/24/2017)... , Jan. 23, 2017 Laboratory Markets ... global use of mass spectrometry in both clinical and ... ,MS analysis, global market size of $6.8 billion and ... next four years, profiles the use of mass spectrometry ... 21 countries. This study investigated growth in the use ...
(Date:1/24/2017)... 2017 Global Market for Pharmaceutical ... A majority of medicines & drugs produced in ... (API), and such processes require alcoholic solvents such as ... of pharmaceutical solvents continues to be concentrated in the ... (APEJ) region as leading API suppliers and ...
Breaking Medicine Technology: